Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × vanucizumab × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Fluorouracil 284 Oxaliplatin 273 Capecitabine 221 Leucovorin 217 Gemcitabine 216 Bevacizumab 200 Irinotecan 168 pembrolizumab 136 Cisplatin 128 Cetuximab 110 Radiotherapy 109 Sorafenib 75 Nivolumab 71 130-nm albumin-bound paclitaxel 63 Paclitaxel 62 Docetaxel 61 Albumin-Bound Paclitaxel 61 Erlotinib Hydrochloride 57 Panitumumab 56 regorafenib 45 Folfox protocol 45 Radiosurgery 44 Sunitinib 40 Radiation 38 Surgical Procedures, Operative 33 Magnetic Resonance Spectroscopy 33 Trastuzumab 32 Ramucirumab 32 durvalumab 31 Carboplatin 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02141295 2020-03-25

McCAVE

Hoffmann-La Roche

Phase 2 Terminated

197 enrolled 24 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡